
MetLife (MET) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
17.2B
Net Income
735.0M
4.28%
EPS (Diluted)
$1.03
Balance Sheet Metrics
Total Assets
688.3B
Total Liabilities
660.6B
Shareholders Equity
27.8B
Debt to Equity
23.80
Cash Flow Metrics
Free Cash Flow
4.3B
Revenue & Profitability Trend
MetLife Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 69.9B | 66.4B | 67.8B | 63.7B | 66.8B |
Cost of Goods Sold | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 6.0B | 6.2B | 5.9B | 5.8B | 5.8B |
Other Operating Expenses | 783.0M | 660.0M | 608.0M | 629.0M | 764.0M |
Total Operating Expenses | 6.8B | 6.8B | 6.5B | 6.4B | 6.5B |
Operating Income | - | - | - | - | - |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 1.0B | 1.0B | 938.0M | 920.0M | 913.0M |
Other Non-Operating Income | 356.0M | 297.0M | 520.0M | 545.0M | 495.0M |
Pre-tax Income | 5.6B | 2.2B | 6.4B | 8.5B | 6.9B |
Income Tax | 1.2B | 560.0M | 1.1B | 1.6B | 1.5B |
Effective Tax Rate % | 21.0% | 25.9% | 16.7% | 19.3% | 21.8% |
Net Income | 4.4B | 1.6B | 5.3B | 6.9B | 5.4B |
Net Margin % | 6.4% | 2.4% | 7.8% | 10.8% | 8.1% |
Key Metrics | |||||
EBITDA | - | - | - | - | - |
EPS (Basic) | $6.13 | $1.81 | $3.02 | $7.70 | $5.81 |
EPS (Diluted) | $6.13 | $1.81 | $2.91 | $7.70 | $5.81 |
Basic Shares Outstanding | 689211065 | 762430939 | 779098414 | 825540267 | 892910600 |
Diluted Shares Outstanding | 689211065 | 762430939 | 779098414 | 825540267 | 892910600 |
Income Statement Trend
MetLife Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 20.1B | 20.6B | 20.2B | 20.0B | 19.8B |
Short-term Investments | 80.5B | 287.5B | 281.7B | 347.4B | 358.7B |
Accounts Receivable | 29.8B | 29.0B | 17.4B | 17.1B | 17.9B |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | - | - | - | - | - |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | 17.8B | 18.5B | 18.6B | 19.1B | 20.2B |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | - | - | - | - | - |
Total Assets | 677.5B | - | - | - | - |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | - | - | - | - | - |
Short-term Debt | 465.0M | 119.0M | 175.0M | 341.0M | 393.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | - | - | - | - | - |
Non-Current Liabilities | |||||
Long-term Debt | 18.2B | 18.7B | 17.8B | 17.1B | 17.8B |
Deferred Tax Liabilities | 132.0M | 927.0M | 950.0M | 9.7B | 11.0B |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | - | - | - | - | - |
Total Liabilities | 649.8B | - | - | - | - |
Equity | |||||
Common Stock | 12.0M | 12.0M | 12.0M | 12.0M | 12.0M |
Retained Earnings | 42.6B | 40.1B | 40.3B | 41.2B | 36.5B |
Treasury Stock | 27.8B | 24.6B | 21.5B | 18.2B | 13.8B |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 27.7B | 30.3B | 30.1B | 67.7B | 74.8B |
Key Metrics | |||||
Total Debt | 18.7B | 18.8B | 18.0B | 17.4B | 18.1B |
Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
MetLife Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 4.4B | 1.6B | 5.3B | 6.9B | 5.4B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -1.9B | -2.3B | -681.0M | -792.0M | -464.0M |
Operating Cash Flow | -1.1B | -4.6B | 897.0M | 2.5B | 1.6B |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | -358.0M | -755.0M | -709.0M | 820.0M | -3.1B |
Investment Purchases | -82.1B | -84.3B | -104.6B | -130.2B | -108.3B |
Investment Sales | 69.9B | 76.1B | 108.4B | 113.9B | 97.0B |
Investing Cash Flow | -12.7B | -9.1B | 3.0B | -15.5B | -14.3B |
Financing Activities | |||||
Share Repurchases | -3.2B | -3.1B | -3.3B | -4.8B | -2.2B |
Dividends Paid | -1.7B | -1.8B | -1.8B | -1.8B | -1.9B |
Debt Issuance | 1.9B | 2.7B | 1.0B | 29.0M | 1.1B |
Debt Repayment | -2.7B | -1.9B | -85.0M | -582.0M | -99.0M |
Financing Cash Flow | -2.9B | 343.0M | 782.0M | -3.0B | 7.2B |
Free Cash Flow | 14.6B | 13.7B | 13.0B | 12.3B | 11.6B |
Net Change in Cash | -16.7B | -13.3B | 4.7B | -16.0B | -5.5B |
Cash Flow Trend
MetLife Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
12.95
Forward P/E
7.87
Price to Book
1.84
Price to Sales
0.69
PEG Ratio
7.87
Profitability Ratios
Profit Margin
5.87%
Operating Margin
5.61%
Return on Equity
15.51%
Return on Assets
0.59%
Financial Health
Current Ratio
1.62
Debt to Equity
171.72
Beta
0.83
Per Share Data
EPS (TTM)
$5.89
Book Value per Share
$41.52
Revenue per Share
$106.39
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
met | 50.7B | 12.95 | 1.84 | 15.51% | 5.87% | 171.72 |
Aflac | 55.4B | 23.32 | 2.04 | 9.15% | 15.32% | 55.06 |
Manulife Financial | 51.2B | 13.31 | 1.08 | 12.39% | 19.36% | 45.07 |
Prudential | 36.4B | 22.80 | 1.19 | 5.80% | 2.76% | 149.73 |
Unum | 11.8B | 8.32 | 1.06 | 13.95% | 11.77% | 35.58 |
Globe Life | 11.4B | 11.25 | 2.10 | 20.02% | 18.11% | 58.82 |
Financial data is updated regularly. All figures are in the company's reporting currency.